QGEN (Qiagen Group) רווח למניה לשנה מתגלגלת

Qiagen N.V. relies on broad geographic expansion and the release of molecular analysis tools, although business success remains limited by regulatory approvals and clinic funding. The rolling annual EPS change on the GURU.Markets chart demonstrates a trend where the value of -5.30 expresses the metric level. Consumables currently provide stable income, while digital PCR technologies create growth potential.
פילוחי מדדים פיננסיים ומדדי שוק עבור qiagen.com (QGEN)

The selection of high-quality issuers is based on the stability of earnings relative to market capitalization. This indicator measures the rolling annual growth of net income per share, identifying the gap between accounting adjustments and actual cash flow. For Qiagen N.V. (QGEN), this is critical during the transition from line robotization to digital data validation. By analyzing the TTM annual net income per share growth trend, an investor can determine the risk of asset overvaluation.